The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human

The purpose of this study is to determine whether YiLi Xinhuo Shuhua Milk is effective in reducing the serum cholesterol in human with hypercholesterolemia.

Study Overview

Detailed Description

In a randomized, placebo-controlled double-blind mono-centric study,179 subjects with total cholesterol (TC) level above 5.18mmol/L and triglyceride (TG) level lower than 2.25mmol/L were assigned to 500ml of low lactose milk enriched with 1.58g plant sterol esters or 500ml plain milk without plant sterols (placebo) or without any dairy product consumption (control) for 60 days. Subjects were instructed to maintain stable diet pattern and physical activity. Plasma concentrations of TC,TG,LDL cholesterol(LDL-C) and HDL cholesterol(HDL-C) were measured at initial visits, after 30days and after 60 days. The primary measurement was the change in TC. Secondary measurements were changes in TG,LDL-C and HDL-C.

Study Type

Interventional

Enrollment (Actual)

179

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100053
        • BaiZhiFang Community Health Service Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female subjects, 18-65 yrs;
  • Serum TC ≥5.18mmol/L, and TG≤2.25mmol/L;
  • Normal blood pressure or able to control blood pressure within normal range;
  • Willing to consent to study participation and to comply with study requirements.

Exclusion Criteria:

  • Pregnant or breastfeeding women;
  • Known allergies to dairy and any substance in the study product.For example lactose intolerance;
  • Any comorbidity that could,in the opinion of the investigator, preclude the subject's ability to successfully and safely complete the study or that may confound study outcomes, including but not limited to cardiac disease, hepatic disease, renal disease, hematopoietic system disease and mental disease;
  • Recent use (within 2 weeks of screening) of any prescription or OTC medication that affects serum total cholesterol or that may confound study outcomes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Milk fortified with plant sterol esters
250mL of Shuhua Milk fortified with plant sterol esters(with plant sterol esters 262mg/100mL) has been taken twice per day. 500mL of Shuhua milk in total has been taken per day during the 60-days intervention.
250mL of Shuhua milk fortified with plant sterol esters(with plant sterol esters 262mg/100mL) has been taken twice per day. 500mL of Shuhua milk in total has been taken per day during the 60-days intervention.
Placebo Comparator: Plain milk
250mL of placebo milk(plain milk) has been taken twice per day. 500mL of plain milk in total has been taken per day during the 60-days intervention.
250mL of placebo milk (plain milk) has been taken twice per day. 500mL of plain milk in total has been taken per day during the 60-days intervention.
No Intervention: No dairy product consumption
Participants have not consumed any dairy product during the 60-days of study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Total Cholesterol(TC) during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
Baseline & 1 months & 2 mongths

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in Triglyceride(TG) during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
Baseline & 1 months & 2 mongths
Change in LDL-C level during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
Baseline & 1 months & 2 mongths
Change in HDL-C level during and after intervention
Time Frame: Baseline & 1 months & 2 mongths
Baseline & 1 months & 2 mongths

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ignatious Szeto, Ph.D, Inner Mongolia Yili Industrial Group Co., Ltd
  • Principal Investigator: Jing Zhu, Beijing Research Institute for Nutrition Resources

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

June 16, 2015

First Submitted That Met QC Criteria

June 16, 2015

First Posted (Estimate)

June 18, 2015

Study Record Updates

Last Update Posted (Estimate)

June 18, 2015

Last Update Submitted That Met QC Criteria

June 16, 2015

Last Verified

July 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypercholesterolemia

Clinical Trials on Milk fortified with plant sterol esters

3
Subscribe